Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients

Publication: Neurology

Giovannoni G, Cohen JA, Coles AJ, Hartung HP, Havrdova E, Selmaj KW, Margolin DH, Lake SL, Kaup SM, Panzara MA, Compston DA; CARE-MS II Investigators

8 November 2016

View publication

© Copyright - NIHR Cambridge Biomedical Research Centre 2025